跳至主要内容
临床试验/CTRI/2024/01/061604
CTRI/2024/01/061604已完成Unknown

A Single Center, Randomized, Interventional, Active Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Lactoferrin Containing Cream In The Treatment Of Patients With Mild To Moderate Acne Vulgaris. - Nil

Frimline Private Limited0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male and Female patients with age 18 - 65 years, with acne vulgaris of face.
  • 2. Written informed consent signed by patient and willing to comply with the study procedure.
  • 3. Patients with mild to moderate acne, as determined by an Investigator Global Assessment (IGA) score of 2 to 3.
  • 4. Females of childbearing potential must have a negative pregnancy test at screening and agree to use an acceptable form of contraception during the study.

排除标准

  • 1. Pregnant Lactating females.
  • 2. Previous hypersensitivity or allergic reaction to any of the components in the study medication.
  • 3. Patients with the skin conditions of the face such as open or incompletely healed wounds at the affected site or acute eczemas, rosacea, perioral dermatitis, atopic-seborrheic dermatitis or psoriasis.
  • 4. Use of topical acne medication within the past 1 weeks.
  • 5. Any significant dermatological condition or skin infection other than acne vulgaris that may interfere with the study assessments.
  • 6. Patients with the significant cardiovascular, hepatic, renal or any other systemic illnesses.
  • 7. Use of any Investigational drug or participation in another clinical trial within the past 30 days.
  • 8. Any other medical or psychological condition that, in the opinion of the investigator, may interfere with the patients ability to participate in the study or complete the study assessments.
  • 9. Any condition or situation that, in the investigators judgment, may put patient at risk or compromise the integrity of the study.

研究者

发起方
Frimline Private Limited

相似试验

Efficacy and safety of the lactoferrin- containing... | 临床试验